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The reaction of [1,2,4]triazolo[4,3-a]pyridinium tetraﬂuoroborates with [RhCl(COD)]2 and
[PdCl(allyl)]2 takes place under mild basic conditions (Et3N, THF, room temperature) to afford the
corresponding [RhCl(COD)(Tripy)] and [PdCl(allyl)(Tripy)] complexes, respectively (Tripy =
[1,2,4]triazolo[4,3-a]pyridin-3-ylidene), and their structures were analysed by X-ray diffractometry and
spectroscopic techniques. The s-donor ability of the new ligands was estimated by comparative analysis
of infrared nCO stretching frequencies of [RhCl(CO)2(Tripy)] complexes, and proved to be strongly
dependent on the substitution pattern. Additionally, a ﬁrst insight into the catalytic properties of the
latter in the Suzuki–Miyaura cross coupling demonstrates a good catalytic activity that enables the
coupling of aryl chlorides at room temperature.
Introduction
The design of new types of ligands has been one of the corner-
stones that enabled the formidable development of homogeneous
catalysis over the past decades. N-Heterocyclic carbenes (NHCs)
have emerged as the younger family of widely used ligands in
transition metals catalysis. The high relevance of these ligands is
founded on the number and importance of the applications, in
turn developed on the basis of their extraordinary characteristics.1
In some aspects, these compounds can be viewed as phosphane
surrogates, the s-donor ability of NHC ligands matching or
improving that of the most basic phosphines. To further exploit
their potential as C-ligands, additional tools for the ﬁne tuning of
their electronic and steric properties are still required.
The main strategies used to tune the electronic properties
of NHCs are the modiﬁcation of the heterocycle core and
their inclusion into bicyclic systems. Taking classic imidazole
and dihydroimidazole derivatives I and II as the basic systems,
structural variability according to the ﬁrst group of modiﬁcations
has been achieved by: (a) substitution of one N atom by
other heteroatoms (e.g. thiazol-2-ylidenes III2), (b) inclusion of
additional heteroatoms in the heterocyclic backbone (e.g. triazole-
3-ylidenes IV),3 (c) modiﬁcation of the heterocycle ring size
(e.g. four membered V),4 six-membered tetrahydropyrimidin-
2-ylidenes (VI),5 and seven-membered 1,3-diazepan-2-ylidenes
(VII),6 (d) removal of one of the stabilizing N atoms, including
not only structures such as pyrrolidin-2-ylidenes VIII,7 but also
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the so-called ‘abnormal’ NHCs IX,8 and the pyridine derivatives
X9 (Fig. 1).
Fig. 1 Structural variation of NHC architectures.
On the other hand, the construction of bicyclic systems by
annulation is another strategy that has been often applied to
modulate the electronic and steric properties of NHC ligands.
Thus, Hahn and co-workers have shown that benzimidazole-
derived ligands XI exhibit modiﬁed properties with respect of


























































analogues I.10 Selected additional examples where benzannulation
at contiguous carbon centres have an impact in the properties
of the NHC ligand include benzothiazole derivatives XII,11
perimidine tricyclic derivative XIII,12 and isoquinoline derived
monoaminocarbenes XIV.13
More recently, our group14 and Glorius et al.15 independently
developed pyrido-annulated bicyclic systems, namely imidazo[1,5-
a]pyridin-3-ylidenes XV. This new NHC architecture is char-
acterized by the inclusion of one of the N atoms as a bridge
to the additional aromatic (pyridine) ring, and thereby offers
interesting possibilities for the electronic modulation of the
carbene ligand, even by using cross-talk communication between
arenes in cyclophane-containing systems.16 A similar annulation
strategy has also been applied to the synthesis of thiazole-
annelated imidazol-2-ylidenes XVI.17
The related [1,2,4]triazolo[4,3-a]pyridin-3-ylidenes XVII were
ﬁrst reported by Enders and co-workers as in situ prepared
organocatalysts in the benzoin condensation.18 Very recently You
and co-workers19 have expanded the study of this carbenes as
organocatalysts, and described a silver complex thereof. The
coordination chemistry of the new family of NHCs, however,
remains unexplored.20 We now wish to disclose our own results on
the synthesis, structure and ligand properties of Rh(I) and Pd(II)
complexes of [1,2,4]triazolo[4,3-a]pyridin-3-ylidenes XVII.
Results and discussion
The most common strategy to the synthesis of NHCs and
their metal complexes require the synthesis of the corresponding
azolium salts as the starting materials. The synthesis of the
required [1,2,4]triazolo[4,3-a]pyridin-2-ium salts 5–8 was accom-
plished in a single step from substituted pyridines 1–4 according
to a modiﬁcation of the original procedure by Eicher and co-
workers21 (Scheme 1).
In order to have a ﬁrst insight into the coordination properties
of the [1,2,4]triazolo[4,3-a]pyridin-3-ylidenes (Tripys), we decide
to prepare the corresponding Rh(I) compounds. Compared to the
above-mentioned imidazopyridinium analogues,14 the additional
N-atom is expected to confer a relatively high acidity to the
[1,2,4]triazolo[4,3-a]pyridin-2-ium salts, a difference that is also
found between the monocyclic triazolium and imidazolium salts.
In fact, this higher acidity makes possible their reaction with
[RhCl(COD)]2 at room temperature in the presence of a weak
base as Et3N. In this way, neutral [RhCl(COD)(Tripy)] complexes
9–12were easily obtained in high (83–93%) yields as robust, bench-
stable compounds, that resisted chromatographic puriﬁcation on
silica-gel (Scheme 2). Of interest, the slightly lower s-donor
ability of these carbenes results also in a different behaviour
with respect to the imidazopyridine (Impy) analogues. Thus,
starting from azolium salts with a non-coordinating counteranion
(hexaﬂuorophosphate), the latter afforded exclusively cationic bis-
carbene [Rh(ImPy)2(COD)]+ complexes in their reaction with
[RhCl(COD)]2,14a even though the Rh : carbene precursor ratio
was 1 : 1.
The structures of compounds 9–12 were assigned on the basis
of their analytical and spectroscopic data. The 13C NMR spectra
showed the characteristic C(2) doublets at d 180–183 (2JRh,C =
50–52 Hz). Additionally, good quality crystals of compounds 10
and 11 suitable for X-ray diffractometry were obtained by slow
Scheme 1 Synthesis of triazolium salts 5–8.
Scheme 2 Synthesis of [RhCl(COD)(Tripy)].
diffusion of hexane into a solution of the complexes in CH2Cl2
(Fig. 2 and 3). Both structures show the expected slightly distorted
square-planar geometry at the Rh centres [C(1)–Rh(1)–Cl(1) =
87.9(3) and 85.56(9)◦, respectively], with the heterocycle plane
oriented near orthogonal to the coordination plane. This geometry
enables Rh–H interactions with H(9) and H(7), respectively,
that, according to the observed Rh–H bond distances (2.761
and 2.497 A˚, respectively), C–H–Rh angles (112.1 and 141.3◦,
respectively) and 1H chemical shifts [dH 9.31 ppm for H(9) in 10;


























































Fig. 2 ORTEP-like drawing of complex 10. Thermal ellip-
soids are drawn at the 30% probability level. Selected bond
lengths [A˚] and bond angles [◦]: Rh(1)–C(1) 2.041(10), N(1)–C(1)
1.349(13), N(3)–C(1) 1.377(14), N(1)–N(2), 1.370(12), Rh(1)–C(14)
2.180(11), Rh(1)–C(15) 2.186(10), Rh(1)–C(18) 2.104(11), Rh(1)–C(19)
2.119(12), Rh(1)–H(9) 2.761; C(1)–Rh(1)–Cl(1) 87.9(3), C(9)–H(9)–Rh(1)
112.05, N(1)–C(1)–N(3) 101.8(8), Cl(1)–Rh(1)–C(1)–N(1) -98.0(9),
Cl(1)–Rh(1)–C(1)–N(3) 73.2(10).
dH 8.31 forH(7) in 11] can be classiﬁed as anagostic interactions.§22
The observed C(carbene)–Rh bond lengths [2.041(12) A˚ (10) and
2.019(3) A˚ (11)] are in the same range as those of related complexes
based on diaminocarbenes [C(carbene)–Rh 2.00–2.06 A˚]. In both
structures, the mean Rh–C(COD) bonds trans to the carbene
ligand are clearly longer (2.183 and 2.199 A˚, respectively) than
those trans to the Cl ligand (2.107 and 2.124 A˚, respectively),
reﬂecting a strong trans inﬂuence of the Tripy ligand.
We decided also to evaluate the effect of the annulation in
the [1,2,4]triazolo[4,3-a]pyridin-3-ylidene ligand properties. One
of the best established methods to evaluate the relative basicity of
a given ligand is based on the analysis of the infrared nCO stretching
frequencies of [M(ligand)X(CO)n] complexes.23 The availability of
data for a number of [RhCl(NHC)(CO)2] complexes prompted
us to synthesize the [RhCl(Tripy)(CO)2] derivatives 13–16. These
compounds were readily obtained from complexes 8–12 through
a fast and quantitative COD to CO ligand exchange, smoothly
performed by bubbling CO through a solution of the latter in
CHCl3 (Scheme 3).
The infrared spectra of 13–16 were recorded in solution and the
observed nCO stretching frequencies are collected in Table 1. These
values indicate a remarkable inﬂuence by the substitution pattern
of the heterocycles in the s-donor ability of some of the ligands.
All of them exhibit a higher basicity than monocyclic triazole-
3-ylidenes,24,25 and, within the series, a higher aromaticity of the
ring condensed with the triazole ring results in a better donor
ability by the ligand (entries 2–4), approaching typical values of
imidazol-2-ylidenes (Fig. 4).
§ Anagostic interactions, also termed “preagostic”, “pregostic” or “pseu-
doagostic” interactions, are characterized by aM–Hdistance range of 2.3–
2.9 A˚, a M–H–C angle range of 110–170◦, and chemical shifts typically
observed downﬁeld of the uncoordinated hydrogen atoms. See ref. 22 for
pertinent discussions.
Fig. 3 ORTEP-like drawing of complex 11. Thermal ellip-
soids are drawn at the 30% probability level. Selected bond
lengths [A˚] and bond angles [◦]: Rh(1)–C(1) 2.019(3), N(1)–C(1)
1.344(4), N(3)–C(1) 1.380(4), N(1)–N(2), 1.382(4), Rh(1)–C(20)
2.188(3), Rh(1)–C(21) 2.210(3), Rh(1)–C(17) 2.125(3), Rh(1)–C(24)
2.123(3), Rh(1)–H(7) 2.497; C(1)–Rh(1)–Cl(1) 85.56(9), C(7)–H(7)–Rh(1)
141.313, N(1)–C(1)–N(3) 102.2(3), Cl(1)–Rh(1)–C(1)–N(1) 94.4(3),
Cl(1)–Rh(1)–C(1)–N(3) -73.5(3).
Scheme 3 Synthesis of [RhCl(Tripy)(CO)2] complexes.
Table 1 nCO stretching frequencies for complexes 13–16
Entry Compound nCO sym/cm-1 nCO asym/cm-1 nCO average/cm-1
1 13 2083 2007 2045
2 14 2078 2004 2041
3 15 2088 2005 2046
4 16 2084 2010 2047
Taking into consideration the growing interest in palladium–
NHC complexes as catalysts in cross-coupling reactions, we
decided to prepare also a series of [PdCl(allyl)(Tripy)] complexes.
Exploiting again their relatively high acidity, salts 6–8 were made
to react with [PdCl(allyl)]2 in the presence of Et3N under mild
conditions (Scheme 4). The expected products 17 and 18 were
obtained in good yields (81 and 75%, respectively) but, in sharp
contrast, the analogous complex 19 was isolated in very poor 16%
yield under the same conditions.¶
¶The steric properties of the carbene ligand in 19 are almost identical to
those of 18. On the other hand, the slight electronic difference (asmeasured
in the IR data of the corresponding [RhCl(Tripy)(CO)2] complexes 15 and
16) can hardly be invoked as a possible reason to explain the marked
difference in the observed behaviour of 19. However, lower stability of the
complex appears to be responsible for the much lower yield of the latter.


























































Fig. 4 Relative donor ability of Tripy ligands.
Scheme 4 Synthesis of [PdCl(allyl)(Tripy)] complexes.
The 1H NMR spectra of these compounds indicated the
presence of two sets of peaks which can be assigned to the mixture
of diastereomers that result from the exo and endo orientation of
the p-allyl ligand.
Suitable crystals of 19 for X-ray diffraction analysis were
obtained by slow diffusion of hexane into a concentrated solution
of the complex in CH2Cl2. The structure reveals the expected
square-planar geometry at the Pd(II) centre and, as in the Rh(I)
cases, the heterocycle plane is oriented near orthogonal to the
coordination plane (Fig. 5), a geometry that enables Pd–H
interactions with H(11) and H(20) that, can also be classiﬁed as
anagostic interactions according to the observed distances [Pd(1)–
H(11) 2.601 A˚; Pd(1)–H(20) 2.792 A˚] and angles [C(11)–H(11)–
Pd(1) 142.6◦; C(20)–H(20)–Pd(1) 104.2]. The Pd–C(allyl) distance
trans to the carbene ligand [Pd(1)–C(21) 2.172(7)] is longer than
that trans to the Cl ligand [Pd(1)–C(23) 2.115(6)], providing also
evidence in this case of a strong trans inﬂuence of the Tripy ligand.
Fig. 5 ORTEP-like drawing of complex 19. Thermal ellipsoids are drawn
at the 30% probability level. Selected bond lengths [A˚] and bond angles [◦]:
Pd(1)–C(1) 2.031(6), N(1)–C(1) 1.386(7), N(2)–C(1) 1.360(7), N(2)–N(3)
1.376(6), Pd(1)–C(23) 2.115(6), Pd(1)–C(21) 2.172(7); Pd(1)–H(11) 2.601,
Pd(1)–H(20) 2.792, C(1)–Pd(1)–Cl(1) 95.17(16), N(2)–C(1)–N(1) 100.4(5),
Cl(1)–Pd(1)–C(1)–N(1) -79.5(6), Cl(1)–Pd(1)–C(1)–N(2) 102.4(4).
A preliminary evaluation of the catalytic activity of complexes
17–19 was attained from the Suzuki–Miyaura cross coupling of
a series of aryl halides with phenyl boronic acid. Similar results
were obtained with catalysts formed in situ from Pd(OAc)2 and
salts 6–8 as the ligand precursor in the presence of K3PO4 as the
base (Scheme 5). The results collected by using Pd(OAc)2/7 as a
representative example are summarized in Table 2. Excellent yields
of the coupling products were observed not only for aryl bromides
(entries 1, 2, 5, 6), but also for less reactive chlorides (entries 3, 4),
even with a low catalyst loading (0.5 mol%) and at relatively low
reaction temperatures.
Scheme 5 Suzuki–Miyaura cross-coupling with Tripy ligands.
Table 2 Cross-coupling of aryl halides with phenyl boronic acid
Entry Starting material T/◦C t/min Isolated yield (%)
1 4-Bromotoluene 25 75 96
2 2-Bromotoluene 25 75 97
3 4-Chlorotoluene 25 75 97
4 Methyl 4-chlorobenzoate 25 75 99
5 1-Bromonaphthalene 25 1800 58
6 1-Bromonaphthalene 65 120 96
Conclusions
In summary, the synthesis of Rh(I) and Pd(II) complexes
based on [1,2,4]triazolo[4,3-a]pyridin-3-ylidene ligands has been


























































accomplished in only two steps from commercially available
pyridine derivatives. The analysis of infrared nCO stretching
frequencies in [RhCl(Tripy)(CO)2] complexes reveals that the
s-donor ability in these new bicyclic NHCs is dependent on the
substitution pattern of the heterocycle. From this study it was also
concluded that the benzannulation of the triazole-5-ylidene system
results in a higher basicity of the NHC ligand.
Experimental
General methods
Solvents were puriﬁed and dried by standard procedures. Flash
chromatography was carried out on silica-gel (0.040–0.063 mm or
0.015–0.040 mm). Melting points were recorded in a metal block
and are uncorrected. 1H NMR spectra were recorded at 300 MHz
or 500 MHz; 13C NMR spectra were recorded at 75 MHz or
125 MHz, with the solvent peak used as the internal reference.
J values are given in Hz.
General procedure for the preparation of
2-phenyl[1,2,4]triazolo[4,3-a]pyridin-2-ium salts 5–8
A Schlenk tube was charged with triethyloxonium tetraﬂuorob-
orate (431 mg, 2.2 mmol) under an argon atmosphere and a
solution of N-methyl-N-nitrosoaniline (300 mg, 2.2 mmol) in dry
dichloroethane (1.5 mL) was added. The reaction mixture was
stirred at room temperature for 1 h and then cooled to 0–5 ◦C.
A solution of the corresponding pyridine derivative (2.6 mmol) in
dry dichloroethane (1.0 mL) was added dropwise and the mixture
stirred for 2 h. The reaction mixture is then warmed up to room
temperature and stirred for 15 h. The solvent was removed in vacuo
and cold CH2Cl2 was added to the residue. The corresponding
triazolium salts were isolated by ﬁltration. Starting materials,
yields and spectral and analytical data for compounds 5–8 are
as follows:
2-Phenyl[1,2,4]triazolo[4,3-a]pyridinium tetraﬂuoroborate (5).
From pyridine (1, 213 mL, 2.6 mmol), 5 (268 mg, 43%) was
obtained as a light brown solid; mp 203–205 ◦C; nmax(ﬁlm)/cm-1
3449, 3005, 1713, 1635, 1497, 1363, 1225, 1187 and 1092;
dH[300 MHz; (CD3)2SO]: 6.61 (1 H, t, J 7.0, py), 6.79–6.88 (3
H, m, Ph), 7.03 (1 H, t, J 7.0, py), 7.16 (2 H, d, J 7.7, Ph), 7.29 (1
H, d, J 7.0, py), 7.94 (1 H, d, J 7.0, py) and 10.52 (1 H, s, 3-H);
dC[75 MHz; (CD3)2SO] 120.1, 127.5, 128.8, 130.4, 134.6, 143.1,
147.0, 148.6, 149.1 and 150.6; m/z (CI) 196.0874 (M+, C12H10N3
requires 196.0872), 108 (11) and 80 (100%)
5-Methyl-2-phenyl[1,2,4]triazolo[4,3-a]pyridinium tetraﬂuorobo-
rate (6). From 2-methylpyridine (2, 267 mL, 2.6 mmol), 6
(248 mg, 38%) was obtained as a white solid; mp 226–228 ◦C;
nmax(ﬁlm)/cm-1 3153, 3126, 2344, 1656, 1540, 1506, 1420, 1287,
1053, 1028, 917, 783, 762 and 682; dH[300 MHz; (CD3)2CO] 2.82
(3 H, s, Me), 7.48 (1 H, d, J 6.9, py), 7.78–7.82 (3 H, m, Ph,
py), 7.97–8.10 (2 H, m, Ph), 8.23–8.26 (2 H, m, Ph) and 11.23 (1
H, s, 3-H); dC[75MHz; (CD3)2CO] 17.2, 112.8, 117.8, 122.0, 130.4,
131.6, 132.3, 135.0, 135.9, 136.9 and 148.6;m/z (CI) 210.1036 (M+,
C13H12N3 requires 210.1031), 209 (63) and 80 (49%).
2-Phenyl[1,2,4]triazolo[4,3-a]quinolinium tetraﬂuoroborate (7).
From quinoline (3, 315 mL, 2.6 mmol), 7 (308 mg, 42%) was
obtained as a light brown solid; mp 214–216 ◦C; nmax(ﬁlm)/cm-1
3118, 2925, 1739, 1629, 1442, 1226, 1056, 1033, 810 and 764;
dH[300 MHz; (CD3)2CO] 7.73–7.83 (3 H, m, Ar), 7.91–7.96 (1 H,
m, Ar), 8.00–8.09 (2 H, m, Ar), 8.24–8.30 (3 H, m, Ar), 8.44 (1
H, d, J 9.9, Ar), 8.74 (1 H, d, J 8.4, Ar) and 11.74 (1 H, s, 3-H);
dC[75 MHz; (CD3)2CO] 112.1, 117.8, 121.7, 124.3, 129.8, 130.4,
131.5, 132.0, 134.0, 135.8, 136.4 and 147.6;m/z (CI) 246.1038 (M+,
C16H12N3 requires 246.1031), 245 (49), 220 (11) and 128 (8%).
2-Phenyl[1,2,4]triazolo[4,3-f ]phenanthridinium tetraﬂuorobo-
rate (8). From phenanthridine (4, 466 mg, 2.6 mmol), 8 (431 mg,
56%) was obtained as a light brown solid; mp 256–258 ◦C;
nmax(ﬁlm)/cm-1 1618, 1571, 1468, 1440, 1239, 1029, 970, 834, 757,
715 and 685; dH[300 MHz; (CD3)2SO] 7.67–7.83 (6 H, m, Ar),
7.89 (1 H, t, J 7.8, Ar), 8.05 (2 H, d, J 7.2, Ar), 8.29 (1 H, d, J 7.8,
Ar), 8.45–8.57 (3 H, m, Ar) and 11.71 (1 H, s, 3-H); dC[75 MHz;
(CD3)2SO] 116.9, 118.3, 121.6, 122.6, 124.1, 125.2, 125.3, 127.3,
129.6, 130.3, 130.5, 130.8, 131.1, 131.8, 134.1, 135.1, 135.3 and
146.9; m/z (CI) 296.1180 (M+, C20H14N3 requires 296.1187), 295
(47), 271 (14), 195 (26), 194 (22), 178 (17) and 104 (11%).
General procedure for the synthesis of RhCl(COD)(2-
phenyl[1,2,4]triazolo[4,3-a]pyridin-3-ylidene) complexes 9–12
To a suspension of 2-phenyl[1,2,4]triazolo[4,3-a]pyridin-2-ium
salts 5–8 (0.13 mmol) and [RhCl(COD)]2 (33.2 mg, 0.065 mmol)
in dry THF (1mL) under Ar was added Et3N (21 mL, 0.143 mmol)
and the mixture was stirred for 4 h at rt. The solvent was removed
in vacuo and the residue puriﬁed by ﬂash chromatography (2 : 1
CH2Cl2–hexane → CH2Cl2 → 100 : 1 CH2Cl2–MeOH). Starting
materials, yields and spectral and analytical data for compounds
9–12 are as follows:
Rhodium(I) complex 9. From 5 (37 mg, 0.13 mmol), ﬂash
chromatography afforded 9 (51 mg, 89%) as a yellow solid; mp
222–224 ◦C; nmax(ﬁlm)/cm-1 2918, 2890, 2827, 1643, 1578, 1493,
1342, 1280, 1056, 798 and 730; dH(500 MHz; C6D6) 1.68–1.84 (4
H, m, 2 ¥ CH2(COD)), 2.17–2.30 (4 H, m, 2 ¥ CH2(COD)), 2.83–2.86 (1
H, m, CH(COD)), 3.02–3.06 (1 H, m, CH(COD)), 5.58–5.62 (1 H, m,
CH(COD)), 5.68–5.72 (1 H, m, CH(COD)), 6.04 (1 H, t, J 7.0, Ar), 6.37
(1 H, td, J 7.0, J 2.2, Ar), 6.79 (1 H, d, J 7.0, Ar), 7.11 (1 H, t, J
7.5, Ph), 7.23 (2 H, t, J 7.5, Ph), 8.95 (2 H, d, J 7.5, Ph) and 9.31
(1 H, d, J 7.0, Ar); dC(125 MHz; C6D6) 28.8, 29.2, 32.1, 33.2, 68.6
(d, JRh,C 13.8), 69.2 (d, JRh,C 12.5), 99.1 (d, JRh,C 6.3), 99.7 (d, JRh,C
7.5), 112.9, 114.4, 124.3, 128.5, 128.6, 130.5, 130.7, 140.5, 148.2
and 181.3 (d, JRh,C 52.0); m/z (CI) 441.0048 (M+, C20H21N3ClRh
requires 441.0036), 406 (96, M - Cl), 196 (48) and 195 (10%,
M - RhClCOD).
Rhodium(I) complex 10. From 6 (40 mg, 0.13 mmol), ﬂash
chromatography afforded 10 (51mg, 86%) as a yellow solid. X-Ray
quality crystals were grown by slowdiffusion of hexane into a solu-
tion of 10 in CH2Cl2; mp 208 ◦C (decomp.); nmax(ﬁlm)/cm-1 2919,
2897, 1652, 1543, 1496, 1413, 1335, 1091 and 764; dH(500 MHz;
C6D6) 1.54–1.70 (4 H, m, 2 ¥ CH2(COD)), 2.07–2.22 (4 H, m, 2 ¥
CH2(COD)), 2.67–2.70 (1H,m,CH(COD)), 2.89–2.93 (1H,m,CH(COD)),
3.82 (3 H, s, Me), 5.38–5.43 (1 H, m, CH(COD)), 5.59–5.64 (1 H, m,
CH(COD)), 5.83 (1H, d, J 6.7, Ar), 6.37 (1H, dd, J 9.0, 8.0, Ar), 6.83
(1 H, d, J 9.0, Ar), 7.12 (1 H, t, J 7.6, Ph), 7.24 (2 H, t, J 7.6, Ph)
and 8.91 (2 H, d, J 7.6, Ph); dC(125 MHz; C6D6) 23.9, 29.0, 29.1,
32.1, 33.2, 67.5 (d, JRh,C 13.9), 70.4 (d, JRh,C 14.3), 96.3 (d, JRh,C 7.5),


























































98.1 (d, JRh,C 7.6), 112.8, 113.5, 126.3, 128.6, 128.9, 130.2, 140.5,
142.3, 150.1 and 180.0 (d, JRh,C 52.0); m/z (CI) 455.0662 (M+,
C21H23N3ClRh requires 455.0636), 420 (100, M - Cl), 312 (5, M -
COD), 210 (38), 209 (7, M - RhClCOD), 75 (58) and 61 (100%).
Crystal structure determination of complex 10.
Crystal data. C21H23ClN3Rh, M = 455.78, monoclinic, space
group C2/c (no. 15), a = 23.5474(17), b = 16.3564(12), c =
9.7329(7) A˚, b = 91.310(3)◦, V = 3747.7(5) A˚3, T = 100(2) K,
Z = 8, 39366 reﬂections measured, 5734 unique (Rint = 0.0487).
The ﬁnal wR(F 2) was 0.1781 (all data).
Rhodium(I) complex 11. From 7 (43 mg, 0.13 mmol), ﬂash
chromatography afforded 11 (59 mg, 93%) as a yellow solid. X-
Ray quality crystals were grown by slow diffusion of hexane into
a solution of 11 in CH2Cl2; mp 232–234 ◦C; nmax(ﬁlm)/cm-1 3343,
2917, 2880, 2833, 1630, 1595, 1561, 1497, 1450, 1356, 1333, 1252,
1064, 863, 804, 758, 729 and 690; dH(500 MHz; CDCl3) 1.59–1.68
(2 H, m, CH2(COD)), 1.87–1.98 (3 H, m, CH2(COD)), 2.19–2.27 (1
H, m, CH2(COD)), 2.34–2.42 (1 H, m, CH2(COD)), 2.47–2.54 (1 H, m,
CH2(COD)), 2.74–2.76 (1H,m, CH(COD)), 3.17 (1H, t, J 7.0, CH(COD)),
5.29–5.34 (2 H, m, CH(COD)), 7.39 (1 H, d, J 9.5, Ar), 7.57 (1 H,
t, J 7.0, Ar), 7.62–7.68 (4 H, m, Ar), 7.77 (1 H, dd, J 8.0, J 1.0,
Ar), 7.94 (1 H, td, J 8.0, J 1.0, Ar), 8.74 (2 H, d, J 8.5, Ar) and
11.67 (1 H, d, J 8.0, Ar); dC(125 MHz; CDCl3) 28.7, 29.1, 31.5,
33.2, 69.2 (d, JRh,C 13.8), 71.2 (d, JRh,C 13.8), 97.5 (d, JRh,C 7.5), 98.9
(d, JRh,C 7.5), 112.9, 121.5, 125.3, 127.1, 128.7, 128.9, 129.0, 130.1,
133.1, 124.1, 133.7, 141.2, 148.4 and 181.3 (d, JRh,C 52.0); m/z (CI)
491.0667 (M+, C24H23N3ClRh requires 491.0636), 456 (100, M -
Cl), 246 (41), 245 (38, M - RhClCOD) and 67 (63%).
Crystal structure determination of complex 11.
Crystal data. C25H25Cl3N3Rh [C24H23ClN3Rh·CH2Cl2], M =
576.74, orthorhombic, space group Pbca (no. 61), a = 11.2461(5),
b = 20.3332(9), c = 20.7475(9) A˚, V = 4744.3(4) A˚3, T = 100(2)
K,Z = 8, 32732 reﬂections measured, 7229 unique (Rint = 0.0358).
The ﬁnal wR(F 2) was 0.1397 (all data).
Rhodium(I) complex 12. From 8 (50 mg, 0.13 mmol), ﬂash
chromatography afforded 12 (58 mg, 83%) as a yellow solid; mp
244 ◦C (decomp.); nmax(ﬁlm)/cm-1 2935, 2879, 2831, 1619, 1598,
1565, 1496, 1462, 1444, 1377, 1306, 1250, 972, 754, 734 and 717;
dH(500 MHz; CDCl3) 1.60–1.68 (2 H, m, CH2(COD)), 1.88–1.98 (3
H, m, CH2(COD)), 2.18–2.27 (1 H, m, CH2(COD)), 2.36–2.43 (1 H,
m, CH2(COD)), 2.50–2.55 (1 H, m, CH2(COD)), 2.76–2.78 (1 H, m,
CH(COD)), 3.19 (1 H, t, J 7.0, CH(COD)), 5.30–5.33 (2 H, m, CH(COD)),
7.57–7.70 (2 H, m, Ar), 7.74–7.77 (3 H, m, Ar), 7.91 (1 H, t, J
7.8, Ar), 8.37 (1 H, d, J 8.0, Ar), 8.41 (1 H, d, J 8.0, Ar), 8.47
(1 H, d, J 7.5, Ar), 8.77 (2 H, d, J 8.0, Ar) and 11.75 (1 H, dd,
J 8.0, 1.0, Ar); dC(125 MHz; CDCl3) 28.7, 29.1, 31.5, 33.1, 69.3
(d, JRh,C 14.0), 71.2 (d, JRh,C 14.1), 97.3 (d, JRh,C 7.4), 98.8 (d, JRh,C
7.4), 119.5, 122.3, 122.7, 123.5, 124.9, 125.4, 127.4, 128.7, 128.8,
128.9, 129.2, 129.7, 131.6, 131.9, 141.3, 148.1 and 182.4; m/z (CI)
541.0818 (M+, C28H25N3ClRh requires 541.0792), 506 (94, M -
Cl), 457 (33), 296 (44), 295 (7, M - RhClCOD), 195 (46) and 67
(100%).
General procedure for the synthesis of dicarbonyl rhodium
complexes 13–16
COwas bubbled through a solution of 9–12 (0.05 mmol) in CDCl3
(0.5 mL) for 15 min. The solvent was then concentrated and the
residue was dried in vacuum to give the dicarbonyl complexes in
quantitative yields. Spectral and analytical data for compounds
13–16 are as follows:
Complex 13. nmax(ﬁlm)/cm-1 2910, 2083, 2007, 1648, 1540,
1500, 1280, 910 and 871; dH(400 MHz; CDCl3) 6.99 (1H, t, J
7.2, Ar), 7.49–7.67 (5H, m, Ar), 8.22 (1H, d, J 7.2, Ar), 8.72 (1H,
d, J 7.2, Ar) and 9.06 (1H, d, J 7.2, Ar); dC(100 MHz; CDCl3)
114.8, 115.0, 124.8 (2C), 125.5, 129.1 (2C), 130.0, 131.9, 139.3,
148.9 (Ar), 170.8 (d, JRh-C 43.5, C-3), 181.2 (d, JRh-C 72.8, CO) and
184.5 (d, JRh-C 55.5,CO);m/z (CI) 391.6226 (M+,C14H11N3ClRhO2
requires 391.6221), 328 (100%, M+ - Cl - CO).
Complex 14. nmax(ﬁlm)/cm-1 2924, 2078, 2004, 1650, 1539,
1497, 1290, 1151 and 911; dH(300 MHz; CDCl3) 3.44 (3H, s, Me),
6.77 (1H, d, J 6.7, py), 7.41 (1H, dd, J 9.3, 6.7, py), 7.56–7.61
(4H, m, H-8, py, Ar) and 8.14–8.18 (2H, m, Ar); dC(75 MHz;
CDCl3) 24.7 (CH3), 113.1, 115.0, 126.1 (2C), 129.0 (2C), 130.0,
131.5, 139.6, 140.6, 150.2 (Ar), 169.6 (d, JRh-C 44.5, C-3), 181.6 (d,
JRh-C 73.9, CO) and 184.9 (d, JRh-C 56.5, CO); m/z (CI) 403.6406
(M+, C15H11N3ClRhO2 requires 403.6394), 340 (100%, M+ - Cl -
CO).
Complex 15. nmax(ﬁlm)/cm-1 3442, 2088, 2005, 1629, 1560, 815
and 763; dH(300 MHz; CDCl3) 7.51–7.68 (5H, m, Ar), 7.78–7.86
(3H, m, Ar), 8.19–8.24 (2H, m, Ar) and 10.49 (1H, d, J 8.4, Ar);
dC(75 MHz; CDCl3) 112.7, 121.0, 124.2, 125.9 (2C), 127.8, 129.1
(2C), 129.3, 130.0, 130.3, 133.1, 133.9, 140.6, 148.8 (Ar), 172.1 (d,
JRh-C 43.8, C-3), 181.3 (d, JRh-C 73.9, CO), 185.0 (d, JRh-C 56.2, CO);
m/z (CI) 439.6720 (M+, C18H11N3RhClO2 requires 439.6727), 376
(100%, M - Cl - CO).
Complex 16. nmax(ﬁlm)/cm-1 3433, 2084, 2047, 2010, 1650,
1628, 1558, 1529, 846 and 751; dH(400 MHz; CDCl3) 7.58–7.69
(5H, m, Ar), 7.74–7.81 (2H, m, Ar), 8.25 (2H, d, J 8.2, Ar), 8.39
(1H, d, J 8.2, Ar), 8.42 (1H, d, J 8.2, Ar), 8.51 (1H, d, J 7.2,
Ar) and 10.52 (1H, d, J 8.2, Ar); dC(100 MHz; CDCl3) 119.0,
121.7, 122.6, 123.8, 125.1, 126.0 (2C), 128.0, 129.1 (2C), 129.2,
129.3, 129.7, 129.9, 131.3, 132.2, 140.7, 148.6 (Ar), 173.2 (d, JRh-C
43.7, C-3), 181.3 (d, JRh-C 73.7, CO), 185.0 (d, JRh-C 55.8, CO);
m/z (CI) 491.7436 (M+, C22H15N3RhClO2 requires 491.7432), 428
(100%, M - Cl - CO).
General procedure for the synthesis of PdCl(allyl)(2-
phenyl[1,2,4]triazolo[4,3-a]pyridin-3-ylidene) complexes 17–19
To a suspension of salts 6–8 (0.1 mmol) and [PdCl(allyl)]2 (17 mg,
0.05 mmol) in dry THF (1 mL) under Ar was slowly added Et3N
(14 mL, 0.11 mmol) and the mixture was stirred for 1 h at rt.
The solvent was removed in vacuo and the residue was puriﬁed by
ﬂash chromatography (2 : 1 EtOAc–hexane). Starting materials,
yields and spectral and analytical data for compounds 17–19 are
as follows:
Monocarbene palladium complex 17. From 6 (29 mg,
0.1 mmol), ﬂash chromatography afforded 17 (30 mg, 81%) as
a light brown solid; dH(300 MHz; CDCl3) 1.82 (0.55 H, d, J 12.0,


























































anti CHH, allyl), 2.32 (0.45 H, d, J 12.0, anti CHH, allyl), 3.05
(0.45, H, d, J 6.9, syn CHH, allyl), 3.22 (0.55 H, d, J 13.2, anti
CHH, allyl), 3.24 (1.65H, s, CH3), 3.30–3.34 (1H,m, CHH, allyl),
3.53 (1.35 H, s, CH3), 4.31 (1 H, td, J 7.2, 2.4, syn CHH, allyl),
4.91–5.04 (0.45 H, m, central CH, allyl), 5.22–5.35 (0.55 H, m,
central CH, allyl), 6.65 (0.55 H, d, J 6.6, CHArom), 6.72 (0.45 H, d,
J 6.9, CHArom), 7.35 (1 H, dd, J 15.6, 9.0, CHArom), 7.45–7.59 (4 H,
m, CHArom), 8.17 (0.9 H, d, J 8.1, CHArom) and 8.39 (1.1 H, d, J 8.1,
CHArom); dC(75 MHz; CDCl3) 22.8, 51.3, 51.8, 71.2, 113.0, 113.0,
113.6, 114.0, 114.1, 114.8, 125.1, 125.3, 128.9, 128.9, 129.2, 129.4,
131.1, 140.1, 140.8, 141.1, 150.1 and 175.6; m/z (CI) 356.0403
(M+ - Cl, C16H16N3Pd requires 356.0379) and 210 (100%).
Monocarbene palladium complex 18. From 7 (54 mg,
0.1 mmol), ﬂash chromatography afforded 18 (51 mg, 75%) as
a white solid; dH(500 MHz; CDCl3) 1.83 (0.67 H, d, J 12.0, anti
CHH, allyl), 2.41 (0.33H, d, J 11.5, antiCHH, allyl), 3.05 (0.41H,
d, J 6.0 Hz, syn CHH, allyl), 3.29–3.33 (1.14 H, m, CHH, allyl),
3.51 (0.45 H, d, J 13.0, anti CHH, allyl), 4.43 (1 H, d, J 7.0, syn
CHH, allyl), 5.00–5.08 (0.41 H, m, central CH, allyl), 5.35–5.47
(0.59 H, m, central CH, allyl), 7.47–7.61 (5 H, m, CHArom), 7.69–
7.79 (3H,m, CHArom), 8.22 (0.89H, d, J 7.5, CHArom), 8.42 (1.11H,
d, J 7.5, CHArom), 10.00 (0.56 H, d, J 8.5, CHArom) and 10.33 (0.44
H, d, J 8.5, CHArom); dC(125 MHz; CDCl3) 51.4, 51.6, 71.8, 72.0,
77.2, 112.6, 112.7, 114.3, 115.3, 119.2, 119.4, 123.9, 124.0, 124.7,
125.0, 127.2, 127.2, 128.9, 129.0, 129.1, 129.1, 129.3, 130.4, 130.5,
133.4, 133.6, 148.6 and 177.6; m/z (FAB) 387 (14, M - allyl), 237
(100), 173 (31), 153 (31) and 131 (69%).
Monocarbene palladium complex 19. From 8 (38 mg,
0.1 mmol), ﬂash chromatography afforded 19 (15 mg, 16%) as
a white solid; dH(500 MHz; CDCl3) 1.88 (d, J 12.5, anti CHH,
allyl), 2.47–2.27 (m, anti CHH, allyl), 3.07 (0.43H, d, J 6.7, syn
CHH, allyl), 3.33–3.29 (1.14H, m, syn CHH + anti CHH, allyl),
3.51 (0.43H, d, J 13.0, anti CHH, allyl), 4.44 (1H, m, anti CHH,
allyl), 5.10–4.95 (0.43H, m, central CH, allyl), 5.44–5.34 (0.57H,
m, central CH, allyl), 8.54–87.36 (12H, m, CHArom), 10.07 (0.57H,
dd, J 8.2, J 0.9, CHArom) and 10.41 (0.43H, d, J 8.1, CHArom);
dC(125 MHz; CDCl3) 51.5, 51.6, 71.7, 72.0, 77.4, 114.4, 115.3,
119.3, 120.0, 120.1, 123.7, 123.9, 124.9, 125.1, 127.5, 129,0, 129,3,
129,5, 129.7, 131,8, 141,0, 141.1, 148.4 and 179.0.
Crystal structure determination of complex 19.
Crystal data. C23H18ClN3Pd, M = 478.25, monoclinic, space
groupP21/c (no. 14), a= 9.5846(6), b= 30.038(2), c= 7.0204(5) A˚,
b = 108.420(3)◦, V = 1917.6(2) A˚3, T = 100(2) K, Z = 4, 15674
reﬂectionsmeasured, 3931unique (Rint = 0.0739). The ﬁnalwR(F 2)
was 0.1274 (all data).
General procedure for Suzuki–Miyaura cross-coupling
A solution of 7 (0.5 mol%, 0.002 mmol) in toluene (1 mL) was
added to a mixture of the aryl halide (0.4 mmol), phenyl boronic
acid (0.6 mmol) and K3PO4 (170 mg, 0.8 mmol). A solution of
Pd(OAc)2 (0.002 mmol) in toluene (1 mL) was then added and
the mixture was stirred until consumption of the starting halide
(TLC monitoring). The resulting residue was puriﬁed by ﬂash
chromatography using hexane as eluent.
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